These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 37767309)

  • 81. Donation after circulatory death liver transplantation: An in-depth analysis and propensity score-matched comparison.
    Hobeika MJ; Saharia A; Mobley CM; Menser T; Nguyen DT; Graviss EA; McMillan RR; Podder H; Nolte Fong JV; Jones SL; Yi SG; Elshawwaf M; Gaber AO; Ghobrial RM
    Clin Transplant; 2021 Jun; 35(6):e14304. PubMed ID: 33792971
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Children undergoing early liver re-transplantation for primary non-function have improved survival.
    Rogers ME; Delman A; Campbell K; Miethke A; Tiao G; Mullapudi B; Bondoc A
    Pediatr Transplant; 2022 Nov; 26(7):e14347. PubMed ID: 35751646
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Good post-transplant outcomes using liver donors after circulatory death when applying strict selection criteria: A propensity-score matched-cohort study.
    Fernández-de la Varga M; Del Pozo-Del Valle P; Béjar-Serrano S; López-Andújar R; Berenguer M; Prieto M; Montalvá E; Aguilera V
    Ann Hepatol; 2022; 27(5):100724. PubMed ID: 35643260
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Center and other factor effects in recipients of living-donor kidney transplants.
    Gjertson DW
    Clin Transpl; 2001; ():209-21. PubMed ID: 12211785
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Independent effect of black recipient race on short-term outcomes after liver transplantation.
    Quillin RC; Wilson GC; Wima K; Hanseman DJ; Sutton JM; Shaw JJ; Cuffy MC; Woodle ES; Paquette I; Abbott DE; Shah SA
    Surgery; 2015 Apr; 157(4):774-84. PubMed ID: 25666335
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Living Donation Versus Donation After Circulatory Death Liver Transplantation for Low Model for End-Stage Liver Disease Recipients.
    Kling CE; Perkins JD; Reyes JD; Montenovo MI
    Liver Transpl; 2019 Apr; 25(4):580-587. PubMed ID: 29637730
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Sequential Organ Failure Assessment (SOFA) Score-Based Factors Predict Early Mortality in High-Risk Patients with Living Donor Liver Transplant.
    Hung HC; Shen CH; Lee CF; Cheng SM; Lee WC
    Ann Transplant; 2021 Jun; 26():e931045. PubMed ID: 34112748
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Impact of sex on the outcomes of deceased donor liver transplantation.
    Andacoglu OM; Dennahy IS; Mountz NC; Wilschrey L; Oezcelik A
    World J Transplant; 2024 Mar; 14(1):88133. PubMed ID: 38576760
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Risk factors for renal impairment after liver transplantation in Mongolia: a retrospective single-center study.
    Batsuuri B; Avirmed S; Batbold C; Lopez-Verdugo F; Nunez J; Togtokh A; Orgoi S
    Clin Transplant Res; 2024 Jun; 38(2):128-135. PubMed ID: 38940688
    [TBL] [Abstract][Full Text] [Related]  

  • 90. COVID-19 infection in liver transplant recipients: Clinical features and outcomes from a Canadian multicentre cohort.
    Smith MK; Chow J; Huang R; Omar M; Ebadi M; Wong P; Huard G; Yoshida EM; Peretz D; Brahmania M; Montano-Loza AJ; Bhanji RA
    Can Liver J; 2022 Nov; 5(4):507-512. PubMed ID: 38144413
    [No Abstract]   [Full Text] [Related]  

  • 91. The Impact of Donor Risk Index, Recipients' and Operative Characteristics on Post Liver Transplant One-Year Graft Failure: A Cohort Analysis.
    Cardoso FS; Bagulho L; Coelho JS; Lamelas J; Mateus É; Mendes M; Glória H; Ribeiro V; Mega R; Pena A; Marques HP; Germano N; Nolasco F; Perdigoto R; Martins A
    GE Port J Gastroenterol; 2023 Aug; 30(4):275-282. PubMed ID: 37767309
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Optimizing repeat liver transplant graft utility through strategic matching of donor and recipient characteristics.
    Hung K; Gralla J; Dodge JL; Bambha KM; Dirchwolf M; Rosen HR; Biggins SW
    Liver Transpl; 2015 Nov; 21(11):1365-73. PubMed ID: 25865434
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Donor Factors Including Donor Risk Index Predict Fibrosis Progression, Allograft Loss, and Patient Survival following Liver Transplantation for Hepatitis C Virus.
    Jesudian A; Desale S; Julia J; Landry E; Maxwell C; Kallakury B; Laurin J; Shetty K
    J Clin Exp Hepatol; 2016 Jun; 6(2):109-14. PubMed ID: 27493458
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Trends and outcomes of liver transplantation among older recipients in the United States.
    Okumura K; Lee JS; Dhand A; Sogawa H; Veillette G; John D; Misawa R; Bodin R; Wolf DC; Diflo T; Nishida S
    World J Transplant; 2022 Aug; 12(8):259-267. PubMed ID: 36159074
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Evaluation of Early Allograft Function Using the Liver Graft Assessment Following Transplantation Risk Score Model.
    Agopian VG; Harlander-Locke MP; Markovic D; Dumronggittigule W; Xia V; Kaldas FM; Zarrinpar A; Yersiz H; Farmer DG; Hiatt JR; Busuttil RW
    JAMA Surg; 2018 May; 153(5):436-444. PubMed ID: 29261831
    [TBL] [Abstract][Full Text] [Related]  

  • 96.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 97.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 98.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.